Company Filing History:
Years Active: 2021
Title: Juma'a Raheem Najeem Al-Dulayymi: Innovator in Mycobacterial Disease Detection
Introduction
Juma'a Raheem Najeem Al-Dulayymi is a notable inventor based in Bangor, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of mycobacterial diseases. His innovative approach has the potential to improve the accuracy and efficiency of disease identification.
Latest Patents
Juma'a holds a patent for a method of determining whether an individual is infected with a mycobacterial disease. The patent describes a system that includes an antigen and outlines a process that involves contacting the system with a sample obtained from the individual. The method further includes detecting the presence or absence of binding of a biomarker in the sample with the antigen, where the antigen is an arabinose ester of a mycolic acid or an analogue thereof. This patent represents a significant advancement in the field of medical diagnostics.
Career Highlights
Juma'a is currently associated with Diagnostig Ltd., where he applies his expertise in developing innovative diagnostic solutions. His work focuses on enhancing the methods used to detect infectious diseases, thereby contributing to public health.
Collaborations
Throughout his career, Juma'a has collaborated with esteemed colleagues, including Mark Stephen Baird and Christopher David Gwenin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Juma'a Raheem Najeem Al-Dulayymi is a pioneering inventor whose work in mycobacterial disease detection is making a significant impact in the medical field. His contributions through patents and collaborations highlight the importance of innovation in improving healthcare outcomes.